Trial NCT02575807

View at ClinicalTrials.gov 
Org. Study IDs: ADU-CL-11

Last trial update was posted on 2019-04-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Ovarian Neoplasms Peritoneal Neoplasms

Other Conditions

Platinum-resistant Fallopian Cancer Platinum-resistant Ovarian Cancer Platinum-resistant Peritoneal Cancer

Stopping Reasons

Study was stopped due to low enrollment and lack of clinical activity.

Limitations And Caveats

Study was terminated early and included a small number of subjects, and insufficient data were available to evaluate the clinical activity of the study treatment. Due to low enrollment, some protocol-specified outcome measures were not evaluated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID